Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Juliane Kania-Almog"'
Autor:
Shmuel Jaffe Cohen, Michail Papoulas, Nadine Graubardt, Esther Ovdat, Shelly Loewenstein, Juliane Kania-Almog, Metsada Pasmanik-Chor, Eli Brazowski, Emanuela Cagnano, Ido Nachmany, Guy Lahat, Joseph M. Klausner, Nir Lubezky
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Solid pseudopapillary neoplasm (SPN) of pancreas is a rare pancreatic neoplasm with a low metastatic potential. Up to 10% of patients with localized disease at presentation will develop systemic metastases, usually in the peritoneum or the liver. Due
Externí odkaz:
https://doaj.org/article/5608d2ab4b734465ab6c0b490e10110a
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e107364 (2014)
The P70 ribosomal protein S6 kinase 1 (P70S6K1) is activated by the mammalian target of rapamycin (mTORC1) and regulates proliferation, growth, and metabolism. PF-4708671 is a novel, cell-permeable, has been proposed to be a highly specific inhibitor
Externí odkaz:
https://doaj.org/article/3cf93284241f408db183ad6b65467b2d
Autor:
Shmuel J. Cohen, Guy Meyerovich, Simcha Blank, Esther Ovdat, Shelly Loewenstein, Juliane Kania-Almog, Meir Cohen, Guy Lahat, Joseph M. Klausner, Nir Lubezky
Publikováno v:
Hepatology Communications. 7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee957776c08ade0d0ce44f1905c16516
https://doi.org/10.1097/hc9.0000000000000164
https://doi.org/10.1097/hc9.0000000000000164
Publikováno v:
Molecular & Cellular Proteomics : MCP
The TOP method is a simple, robust, environment friendly proteome extraction method, with decreased fixation time bias. Using the TOP method, we analyzed by LC\MS-MS a clinical cohort of microsatellite stable (MSS) and unstable (MSI-H) colorectal car
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7325e91edbe7efa69056d0918127028f
http://europepmc.org/articles/PMC8015011
http://europepmc.org/articles/PMC8015011
Autor:
Gilad W. Vainer, Judith Sandbank, Yaniv Zohar, Tzahi Neuman, Juliane Kania-Almog, Michal London, Iris Barshak, Anna Litvin, Ludmila Fridel
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 11(11)
Immunotherapy is a novel treatment for lung cancer. Pembrolizumab (Merck Sharp and Dohme, Kenilworth, NJ) is a monoclonal antibody against programmed cell death 1 that has been approved for use with NSCLC together with a companion diagnostic by Dako
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b9a05ea8b53458f7da3e09ff826704a
https://pubmed.ncbi.nlm.nih.gov/27664534
https://pubmed.ncbi.nlm.nih.gov/27664534